| 1. | | Recruiting | Evaluation of Patients with Blood Disorders
Condition: Hematologic Disease |
| 2. | | Recruiting | Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease; Hematologic Diseases |
| 3. | | Recruiting | Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorder |
| 4. | | Recruiting | Medical Treatment for Diamond Blackfan Anemia
Conditions: Fanconi's Anemia; Hematologic Disease |
| 5. | | Recruiting | Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes
Conditions: Aplastic Anemia; Fanconi's Anemia; Healthy; Hematologic Disease; Myelodysplastic Syndrome |
| 6. | | Recruiting | Evaluation, Treatment, and Training for Patients with Blood Disorders
Conditions: Hematologic Disease; Hematologic Neoplasm; Pancytopenia |
| 7. | | Not yet recruiting | Transfusion Medicine/Hemostasis Clinical Research Network
Conditions: Purpura, Thrombocytopenic; Blood Disease |
| 8. | | Recruiting | Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
Conditions: Anemia; Blood Disease; Blood Transfusion; Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Thromboembolism; Pneumonia; ... |
| 9. | | Recruiting | Induction of Stable Chimerism for Sickle Cell Anemia
Conditions: Blood Disease; Hematopoietic Stem Cell Transplantation; Anemia, Sickle Cell |
| 10. | | Not yet recruiting | Sibling Donor Cord Blood Banking and Transplantation
Conditions: Blood Disease; Anemia, Sickle Cell; Anemia (Cooley's); Leukemia; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation |
| 11. | | Recruiting | Blood and Marrow Transplant Clinical Research Network
Conditions: Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; ... |
| 12. | | Recruiting | Pediatric Hydroxyurea in Sickle Cell Anemia (BABY HUG)
Conditions: Blood Disease; Anemia, Sickle Cell |
| 13. | | Recruiting | Stroke Prevention in Sickle Cell Anemia (STOP 2)
Conditions: Blood Disease; Cerebrovascular Accident; Anemia, Sickle Cell |
| 14. | | Recruiting | Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
Conditions: Anemia (Cooley's); beta-Thalassemia; Blood Disease; Thalassemia; Osteoporosis |
| 15. | | Recruiting | Collection of Tissue Specimens from Patients with Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Conditions: Neoplasms; Hematologic Neoplasms |
| 16. | | Recruiting | Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
Conditions: Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ... |
| 17. | | Recruiting | Study of Unrelated Allogeneic Bone Marrow Transplantation in Patients With Benign Congenital Bone Marrow Failure Disorders
Conditions: Graft Versus Host Disease; Neutropenia; Shwachman syndrome; Red-Cell Aplasia, Pure; Osteopetrosis |
| 18. | | Recruiting | Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
Condition: Sickle Cell Anemia |
| 19. | | Recruiting | Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
Condition: Sickle Cell Anemia |
| 20. | | Recruiting | Study of High Dose Cyclophosphamide in Patients with Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Conditions: Aplastic Anemia; Paroxysmal Hemoglobinuria, Nocturnal |
| 21. | | Recruiting | Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
Conditions: Skin Ulcers; Sickle Cell Anemia |
| 22. | | Recruiting | Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
Condition: Sickle Cell Anemia |
| 23. | | Recruiting | International Registry for Severe Chronic Neutropenia
Condition: Neutropenia |
| 24. | | Recruiting | Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects with Anemia of Cancer
Condition: Anemia |
| 25. | | Recruiting | A Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes |
| 26. | | Recruiting | Tipifarnib versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Myeloid Leukemia; Acute Disease |
| 27. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
| 28. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 29. | | Recruiting | Darbepoetin alfa in Treating Anemic Patients With Myelodysplastic Syndromes
Conditions: Anemia; Fatigue; Myelodysplastic Syndromes |
| 30. | | Recruiting | PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ... |
| 31. | | Recruiting | Anti-Thymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia |
| 32. | | Recruiting | Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 33. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes |
| 34. | | Recruiting | Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 35. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 36. | | Recruiting | Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) with Hemophilia B
Condition: Hemophilia B |
| 37. | | Recruiting | Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
Condition: Multiple Myeloma |
| 38. | | Recruiting | ReFacto® in Subjects with Hemophilia A Undergoing Major Surgery
Condition: Hemophilia A |
| 39. | | Recruiting | Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)
Condition: Anemia |
| 40. | | Recruiting | A Longitudinal Study of Familial Hyperosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Eosinophilia |
| 41. | | Recruiting | Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer
Conditions: Anemia; Cancer |
| 42. | | Recruiting | A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
Condition: Multiple Myeloma |
| 43. | | Recruiting | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 44. | | Recruiting | Epoetin alfa in Treating Cancer-Related Anemia in Patients With Non-Myeloid Cancer Who Are Not Currently Receiving Chemotherapy or Radiation Therapy
Conditions: adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm |
| 45. | | Not yet recruiting | Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combination with DTPACE Chemotherapy and Autologous Transplantation in Multiple Myeloma
Condition: Multiple Myeloma |
| 46. | | Recruiting | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
| 47. | | Recruiting | Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
Condition: Multiple Myeloma |
| 48. | | Recruiting | Cilengitide in Treating Patients With Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 49. | | Recruiting | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 50. | | Recruiting | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
